作为个性化癌症免疫治疗中的新兴检查点和生物标志物,HLA-E
Rajeswary Sanmugawil1,2, Lhoshiny Parmeswaran1,2, Nafisah Abdul Rahman3
1Department of Biomedical Science, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, 13200, Bertam, Kepala Batas, Penang, Malaysia.
Current medical science
|March 6, 2026
概括
人类白细胞抗原E (HLA-E) 通过抑制自然杀手 (NK) 和T细胞活性,在癌症免疫逃避中发挥关键作用. 向HLA-E提供了一个有前途的策略,以提高癌症免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 人类白细胞抗原 (HLA) 分子对免疫反应至关重要,可以区分自我与非自我.
- 一类HLA分子与T细胞受体 (TCR) 相互作用,激活T细胞,这对适应性免疫至关重要.
- HLA多样性影响了癌症免疫疗法的疗效,如检查点抑制剂和CAR-T细胞疗法.
研究的目的:
- 审查人类白细胞抗原E (HLA-E) 在癌症免疫逃避中的作用.
- 要总结最近在识别HLA-E受限制的进展.
- 评估当前的HLA-E依赖和独立的采用免疫疗法.
主要方法:
- 对癌症中HLA-E表达和功能研究的文献综述.
- 分析HLA-E与自然杀手 (NK) 细胞和T细胞子集的相互作用.
- 对针对HLA-E的治疗策略的评估.
主要成果:
- HLA-E表现出免疫抑制性质,有助于瘤免疫逃逸.
- 瘤细胞表达HLA-E抑制NK和CD8+T细胞的细胞毒性活动.
- 识别HLA-E受限可以促进免疫治疗的发展.
结论:
- 了解HLA-E在免疫逃避中的作用,为新的个性化癌症免疫疗法提供了洞察力.
- 向HLA-E可能会提高现有癌症治疗的有效性.
- 调节HLA-E为改善各种癌症患者预后提供了一个有希望的途径.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K


